Pembrolizumab versus chemotherapy in recurrent, advanced urothelial cancer in Japanese patients: a subgroup analysis of the phase 3 KEYNOTE-045 trial - Concepedia

Concepedia

Publication | Open Access

Pembrolizumab versus chemotherapy in recurrent, advanced urothelial cancer in Japanese patients: a subgroup analysis of the phase 3 KEYNOTE-045 trial

DOI Full Paper Access

41

Citations

23

References

2019

Year

Hiroyuki Nishiyama, Yoshiaki Yamamoto, Naoto Sassa, Kazuo Nishimura, Kiyohide Fujimoto, Satoshi Fukasawa, Minato Yokoyama, Hideki Enokida, Kenichi Takahashi, Yoshinobu Tanaka,

International Journal of Clinical Oncology

References

	Year	Citations

Page 1